Iron metabolism and iron chelation in the thalassaemia disorders.
Pippard
M J
MJ
Department of Haematology, Ninewells Hospital and Medical School, University of Dundee, Scotland, UK.
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D001206:Ascorbic Acid Deficiency / Q000209:etiology; D001646:Bile / Q000378:metabolism; D015913:Chelation Therapy; D003676:Deferoxamine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004920:Erythropoiesis; D006486:Hemosiderosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007408:Intestinal Absorption; D007501:Iron / Q000378:metabolism*; D051381:Rats; D013789:Thalassemia / Q000150:complications / Q000378:metabolism* / Q000628:therapy; D065227:Transfusion Reaction
D007501:Iron; D003676:Deferoxamine; D001205:Ascorbic Acid